Ratings actions from Benzinga: https://www.benzinga.com/quote/SNTI/analyst-ratings
(END) Dow Jones Newswires
Ratings actions from Benzinga: https://www.benzinga.com/quote/SNTI/analyst-ratings
(END) Dow Jones Newswires
Laidlaw & Co. announced at $15.00/share price target on Senti Biosciences. "Senti Biosciences Price Target Announced at $5.00/Share by Laidlaw & Co." at 9:02 a.m. ET misstated the price target as $5.00/share.
(END) Dow Jones Newswires
June 06, 2025 12:15 ET (16:15 GMT)